
|Articles|May 15, 2020
ASCRS 2020: TearClear CEO shares company's vision, mission for future
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Robert Dempsey, TearClear's new CEO, on his goals for the company, its mission and vision in the future of the coronavirus, as well as what to keep an eye out for at the 2020 ASCRS virtual meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
3
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
4
From detection to decision-making: Navigating disease progression and treatment in geographic atrophy
5
























